# FDA Inspection 1220242 - Evonik Operations GmbH - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/evonik-operations-gmbh/e0f38782-1e92-4cf4-ab28-cba5de368f9a
Source feed: FDA_Inspections

> FDA Inspection 1220242 for Evonik Operations GmbH on September 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1220242
- Company Name: Evonik Operations GmbH
- Inspection Date: 2023-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1031211 - 2017-09-29](https://www.keypedia.com/records/fda_inspections/evonik-operations-gmbh/2b27aa68-0955-4669-9b28-d896e3428df8)
- [FDA Inspection 871218 - 2014-03-21](https://www.keypedia.com/records/fda_inspections/evonik-operations-gmbh/9db89f96-78b1-4154-8b7c-a020755eb0d2)
- [FDA Inspection 576022 - 2009-04-01](https://www.keypedia.com/records/fda_inspections/evonik-operations-gmbh/cac38f08-fafe-4388-9269-762648dff7ad)

Company: https://www.keypedia.com/companies/evonik-operations-gmbh/393e2b2c-e80c-441e-b032-b8cca608755d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c